Sources and Releases
Data Sources
| Name | Data types | Version | Last update |
|---|---|---|---|
| cancer.gov | Drug Indications | - | Sep 27, 2023 |
| clinicaltrials.gov | Clinical Trials | - | Sep 27, 2023 |
| PDB | 3D Crystal Structures | - | Sep 20, 2023 |
| UniProt | Proteins | 2023_04 | Sep 13, 2023 |
| ChEMBL | Compounds, Bioactivity Data | ChEMBL 32 | Jan 26, 2023 |
| Phosphosite | Interactions | - | Sep 9, 2022 |
| canSAR ligandable interactions | Interactions | - | Aug 20, 2022 |
| IMEx | Interactions | - | Aug 20, 2022 |
| Signor2 | Interactions | - | Apr 27, 2021 |
| Other trusted sources and publications | Interactions | - | Jan 14, 2021 |
canSAR.ai 3D structure data timeline
*Select a region to zoom. **Click chart point to view release details
Data Counts
| Type | # |
|---|---|
| 3D Structures |
206,531 structures, 644,822 chains
|
| Cancer studies |
TCGA: 33
ICGC: 61
|
| Cell Lines |
35,548
|
| Chemical Bioactivities |
12,207,767 datapoints from 76,402 studies
|
| Clinical Trials |
467,212
|
| Compounds |
3,935,402 unique structures
|
| Copy Number Alterations |
DepMap: 34,530,423
ICGC/TCGA: 107,050,671
|
| Gene Expression |
TCGA: 218,210,403
DepMap: 23,118,260
|
| Interactions by host |
1,006,700 (human)
5,166 (coronavirus-human)
2,855 (Cov2)
1,560 (SARS)
607 (MERS)
144 (other coronavirus)
|
| Interactions by type |
Signalling pathways: 103,444
Enzymatic reactions: 9,203
Direct binding: 138,483
In same complex: 389,600
Transcriptional: 117,380
Drug Synergies: 12,118
Low confidence complex: 241,815
|